1.69 USD
↘ 0.06 (3.43%)LIVE (AS OF 02:22 PM EST)
Shares of Grace Therapeutics, Inc. Common Stock (GRCE) are trading at $1.69. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, GRCE appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.